Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-005713
Filing Date
2023-03-02
Accepted
2023-03-02 07:31:06
Documents
121
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K verv-20221231.htm   iXBRL 10-K 4756656
2 EX-10.5 verv-ex10_5.htm EX-10 80579
3 EX-10.7 verv-ex10_7.htm EX-10 42726
4 EX-10.22 verv-ex10_22.htm EX-10 243792
5 EX-23.1 verv-ex23_1.htm EX-23 7678
6 EX-31.1 verv-ex31_1.htm EX-31 20991
7 EX-31.2 verv-ex31_2.htm EX-31 20983
8 EX-32.1 verv-ex32_1.htm EX-32 11979
9 EX-32.2 verv-ex32_2.htm EX-32 12212
10 GRAPHIC img243551639_0.jpg GRAPHIC 19311
11 GRAPHIC img243551639_1.jpg GRAPHIC 9839
12 GRAPHIC img243551639_2.jpg GRAPHIC 19417
13 GRAPHIC img243551639_3.jpg GRAPHIC 21207
14 GRAPHIC img243551639_4.jpg GRAPHIC 10534
15 GRAPHIC img243551639_5.jpg GRAPHIC 12117
16 GRAPHIC img243551639_6.jpg GRAPHIC 79922
17 GRAPHIC img243551639_7.jpg GRAPHIC 8446
18 GRAPHIC img243551639_8.jpg GRAPHIC 25620
19 GRAPHIC img243551639_9.jpg GRAPHIC 19305
20 GRAPHIC img243551639_10.jpg GRAPHIC 14038
21 GRAPHIC img243551639_11.jpg GRAPHIC 20958
22 GRAPHIC img243551639_12.jpg GRAPHIC 62211
23 GRAPHIC img243551639_13.jpg GRAPHIC 15411
24 GRAPHIC img243551639_14.jpg GRAPHIC 29869
25 GRAPHIC img243551639_15.jpg GRAPHIC 13096
26 GRAPHIC img243551639_16.jpg GRAPHIC 70301
27 GRAPHIC img243551639_17.jpg GRAPHIC 14170
28 GRAPHIC img243551639_18.jpg GRAPHIC 12810
29 GRAPHIC img243551639_19.jpg GRAPHIC 13041
30 GRAPHIC img243551639_20.jpg GRAPHIC 75424
31 GRAPHIC img243551639_21.jpg GRAPHIC 62867
32 GRAPHIC img243551639_22.jpg GRAPHIC 18345
33 GRAPHIC img243551639_23.jpg GRAPHIC 21249
34 GRAPHIC img243551639_24.jpg GRAPHIC 20570
35 GRAPHIC img243551639_25.jpg GRAPHIC 12619
36 GRAPHIC img243551639_26.jpg GRAPHIC 66366
37 GRAPHIC img243551639_27.jpg GRAPHIC 50111
38 GRAPHIC img243551639_28.jpg GRAPHIC 39359
  Complete submission text file 0000950170-23-005713.txt   17394108

Data Files

Seq Description Document Type Size
39 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT verv-20221231_cal.xml EX-101.CAL 59047
40 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT verv-20221231.xsd EX-101.SCH 90894
41 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT verv-20221231_pre.xml EX-101.PRE 526995
42 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT verv-20221231_def.xml EX-101.DEF 322329
43 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT verv-20221231_lab.xml EX-101.LAB 709519
115 EXTRACTED XBRL INSTANCE DOCUMENT verv-20221231_htm.xml XML 2759810
Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Filer) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40489 | Film No.: 23696424
SIC: 2834 Pharmaceutical Preparations